BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 613244)

  • 1. Lymphoproliferative and myeloproliferative disease in Tasmania.
    Lickiss JN; Baikie AG; Panton J
    Natl Cancer Inst Monogr; 1977 Dec; 47():37-9. PubMed ID: 613244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
    Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
    Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pattern of haematological and lymphoreticular malignancy in Zimbabwe.
    Levy LM
    Trop Geogr Med; 1988 Apr; 40(2):109-14. PubMed ID: 3406999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloproliferative and lymphoproliferative disorders in Tasmania, 1972-80: patterns in space and time.
    Lickiss JN; Giles GG; Baikie MJ; Lowenthal RM; Challis D; Panton J
    J Natl Cancer Inst; 1984 Jun; 72(6):1223-31. PubMed ID: 6587144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An Italian multicenter case-control study on malignant neoplasms of the hematolymphopoietic system. Hypothesis and preliminary results on work-related risks. WILL (Working Group on Hematolymphopoietic Malignancies in Italy)].
    Costantini AS; Miligi L; Vineis P
    Med Lav; 1998; 89(2):164-76. PubMed ID: 9673106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second cancer following lymphatic and hematopoietic cancers in Connecticut, 1935-82.
    Greene MH; Wilson J
    Natl Cancer Inst Monogr; 1985 Dec; 68():191-217. PubMed ID: 4088298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inheritance in lymphoproliferative disorders].
    Jønsson V; Olsen JH
    Ugeskr Laeger; 2006 Jun; 168(24):2361-6. PubMed ID: 16822421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Health databases to assess the incidence of lymphoid malignancies in Italian population].
    Borciani N; Vinceti M; Avanzini P; Ilariucci F; Mangone L; Martini M; Merlin M; Ferretti A; Frassineti M; Rodolfi R; Bergomi M
    Epidemiol Prev; 2000; 24(2):81-4. PubMed ID: 10863849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographical variation in the incidence of the leukemias and lymphomas.
    Weiss NS
    Natl Cancer Inst Monogr; 1979 Nov; (53):139-42. PubMed ID: 295090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France.
    Hausfater P; Cacoub P; Sterkers Y; Thibault V; Amoura Z; Nguyen L; Ghillani P; Leblond V; Piette JC
    Am J Hematol; 2001 Jul; 67(3):168-71. PubMed ID: 11391713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal relationships of leukemia and lymphoma deaths in neighborhoods.
    Lundin FE; Fraumeni JF; Lloyd JW; Smith EM
    J Natl Cancer Inst; 1966 Aug; 37(2):123-33. PubMed ID: 5912609
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence of hematopoietic malignancies in a well-defined population in France.
    Carli PM; Milan C; Lorenzini JL; Guy H; Michiels R
    Oncology; 1986; 43(6):354-7. PubMed ID: 3808567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloproliferative and lymphoproliferative disorders in Tasmania, 1972-80: occupational and familial aspects.
    Giles GG; Lickiss JN; Baikie MJ; Lowenthal RM; Panton J
    J Natl Cancer Inst; 1984 Jun; 72(6):1233-40. PubMed ID: 6587145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
    Jakó J; Szerafin L; Nagy P
    Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Number of siblings and the risk of lymphoma, leukemia, and myeloma by histopathology.
    Altieri A; Castro F; Bermejo JL; Hemminki K
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1281-6. PubMed ID: 16835324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Incidence of leukemia and other hemoblastoses].
    Martirosov AR; Osechinskiĭ IV
    Klin Med (Mosk); 1975 Apr; 53(4):19-25. PubMed ID: 1097809
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cases of familial leukemia-lymphoma in Szabolcs-Szatmár-Bereg County].
    Jakó J; Szerafin L; Póth I; Nagy P; Smanykó D; Babicz T
    Orv Hetil; 1992 Jan; 133(3):147-8, 153. PubMed ID: 1734343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second cancer following lymphatic and hematopoietic cancers in Denmark, 1943-80.
    Storm HH; Prener A
    Natl Cancer Inst Monogr; 1985 Dec; 68():389-409. PubMed ID: 4088311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cigarette smoking, alcohol drinking, and risk of lymphoid neoplasms: results of a French case-control study.
    Monnereau A; Orsi L; Troussard X; Berthou C; Fenaux P; Soubeyran P; Marit G; Huguet F; Milpied N; Leporrier M; Hemon D; Clavel J
    Cancer Causes Control; 2008 Dec; 19(10):1147-60. PubMed ID: 18781390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.